title: Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia.
authors.affiliation: r.greil@salk.at.
authors.forename: Franz J
authors.initials: FJ
authors.lastname: Gassner
authors.forename: Nadja
authors.initials: N
authors.lastname: Zaborsky
authors.forename: Daniel
authors.initials: D
authors.lastname: Neureiter
authors.forename: Michael
authors.initials: M
authors.lastname: Huemer
authors.forename: Thomas
authors.initials: T
authors.lastname: Melchardt
authors.forename: Alexander
authors.initials: A
authors.lastname: Egle
authors.forename: Stefan
authors.initials: S
authors.lastname: Rebhandl
authors.forename: Kemal
authors.initials: K
authors.lastname: Catakovic
authors.forename: Tanja N
authors.initials: TN
authors.lastname: Hartmann
authors.forename: Richard
authors.initials: R
authors.lastname: Greil
authors.forename: Roland
authors.initials: R
authors.lastname: Geisberger
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects*; D006801:Humans; D060828:Induction Chemotherapy; D000077269:Lenalidomide; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology*; D011971:Receptors, Immunologic / Q000235:genetics*; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D011971:Receptors, Immunologic; D013792:Thalidomide; D000077269:Lenalidomide
keywords: T cell imhibitory receptors; chronic lymphocytic leukemia; lenalidomide